Granell-Geli, J.; Izquierdo-Gracia, C.; Sellés-Rius, A.; Teniente-Serra, A.; Presas-RodrÃguez, S.; Mansilla, M.J.; Brieva, L.; Sotoca, J.; Mañé-MartÃnez, M.A.; Moral, E.;
et al. Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab. J. Pers. Med. 2021, 11, 1347.
https://doi.org/10.3390/jpm11121347
AMA Style
Granell-Geli J, Izquierdo-Gracia C, Sellés-Rius A, Teniente-Serra A, Presas-RodrÃguez S, Mansilla MJ, Brieva L, Sotoca J, Mañé-MartÃnez MA, Moral E,
et al. Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab. Journal of Personalized Medicine. 2021; 11(12):1347.
https://doi.org/10.3390/jpm11121347
Chicago/Turabian Style
Granell-Geli, Júlia, Cristina Izquierdo-Gracia, Ares Sellés-Rius, Aina Teniente-Serra, Silvia Presas-RodrÃguez, MarÃa José Mansilla, Luis Brieva, Javier Sotoca, MarÃa Alba Mañé-MartÃnez, Ester Moral,
and et al. 2021. "Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab" Journal of Personalized Medicine 11, no. 12: 1347.
https://doi.org/10.3390/jpm11121347
APA Style
Granell-Geli, J., Izquierdo-Gracia, C., Sellés-Rius, A., Teniente-Serra, A., Presas-RodrÃguez, S., Mansilla, M. J., Brieva, L., Sotoca, J., Mañé-MartÃnez, M. A., Moral, E., Bragado, I., Goelz, S., MartÃnez-Cáceres, E., & Ramo-Tello, C.
(2021). Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab. Journal of Personalized Medicine, 11(12), 1347.
https://doi.org/10.3390/jpm11121347